Medicaments nes, in dosage300490 (Harmonized System 1992 for 6-digit)
World Trade (2018): $290B, Rnk 6 / 4726
Top Exporter (2018): $45.1B, Germany
Top Importer (2018): $55.7B, United States
Product Complexity (2018): 0.47, Rnk 1038 / 2722
Export Growth (CAGR)(2017 - 2018): 9.47%, Rnk 2758 / 4726
Mean Tariff (2018): 3.22%, Rnk 5586 / 6538
Share of World Trade (2018): 1.58%, Rnk 6 / 4726
Overview: This page contains the latest trade data of Medicaments nes, in dosage. In 2018, Medicaments nes, in dosage were the world's 6th most traded product, with a total trade of $290B. Between 2017 and 2018 the exports of Medicaments nes, in dosage grew by 9.47%, from $265B to $290B. Trade in Medicaments nes, in dosage represent 1.58% of total world trade.
Exports: In 2018 the top exporters of Medicaments nes, in dosage were Germany ($45.1B), Switzerland ($39.4B), Ireland ($25.9B), United States ($22.4B), and Belgium-Luxembourg ($18.1B).
Imports: In 2018 the top importers of Medicaments nes, in dosage were United States ($55.7B), Germany ($23.6B), Switzerland ($14.5B), United Kingdom ($14B), and Netherlands ($13.8B).
Tariffs: In 2018 the average tariff for Medicaments nes, in dosage was 3.22%, been the 5586 lowest tariff using the HS6 product classification.
The countries with the highest import tariffs for Medicaments nes, in dosage are Iran (14.5%), Pakistan (14.2%), Bermuda (12.5%), Barbados (11.4%), and Nepal (11.2%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).
Ranking: Medicaments nes, in dosage ranks 1038th in the Product Complexity Index (PCI).
Trade By Country
Top Origin (2018): Germany, $45.1B
Top Destination (2018): United States, $55.7B
Medicaments nes, in dosage are the world's 6th most traded product.
In 2018, the top exporters of Medicaments nes, in dosage were Germany ($45.1B), Switzerland ($39.4B), Ireland ($25.9B), United States ($22.4B), and Belgium-Luxembourg ($18.1B).
In 2018, the top importers of Medicaments nes, in dosage were United States ($55.7B), Germany ($23.6B), Switzerland ($14.5B), United Kingdom ($14B), and Netherlands ($13.8B).
Trade by country
Top Origin Growth (2017 - 2018): Switzerland, $7.45B
Top Destination Growth (2017 - 2018): Netherlands, $6.19B
Between 2017 and 2018, the exports of Medicaments nes, in dosage grew the fastest in Switzerland ($7.45B), Belgium-Luxembourg ($6.31B), Germany ($4.89B), Netherlands ($3.56B), and Singapore ($2B).
Between 2017 and 2018, the fastest growing importers of Medicaments nes, in dosage were Netherlands ($6.19B), United States ($3.88B), Australia ($3.81B), Denmark ($1.9B), and Germany ($1.39B).
Cumulative market share
This chart shows the evolution of the market concentration of exports of Medicaments nes, in dosage.
In 2018, market concentration measured using Shannon Entropy, was 4.34. This means that most of the exports of Medicaments nes, in dosage are explained by 20 countries.
TOP NET EXPORTER (2018): Switzerland, $25B
TOP NET IMPORTER (2018): United States, $33.2B
This map shows which countries export or import more of Medicaments nes, in dosage. Each country is colored based on the difference in exports and imports of Medicaments nes, in dosage during 2018.
In 2018, the countries that had a largest trade value in exports than in imports of Medicaments nes, in dosage were Switzerland ($25B), Ireland ($23B), Germany ($21.5B), India ($10.9B), and Singapore ($6.81B).
In 2018, the countries that had a largest trade value in imports than in exports of Medicaments nes, in dosage were United States ($33.2B), China ($8.44B), Japan ($7.2B), Russia ($5.96B), and Australia ($2.43B).
The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v4.0.2 ant